At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin (STOP-Vanc)
In Brief
A clinical study evaluating MRSA Nasal Swab PCR for Community-acquired Pneumonia. Completed, enrolled 277 participants across 1 site.
Detailed Summary
This is a single center, pragmatic, randomized clinical trial (pRCT) examining whether reporting the results of a negative rapid PCR back to the provider via a pager alert results in decreased vancomycin utilization for critically ill adults with community-acquired pneumonia when compared with usual care.
Study Details
Timeline
Interventions
For the subjects assigned to the intervention group who have a negative MRSA nasal swab PCR result, providers will receive a pager alert which inform them of the negative result and will direct clinicians to clinical guidance recommending clinicians to discontinue vancomycin, if clinically appropriate.